[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356053-105":59,"doc-detail-356053-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","complex-structural-variations-functionally-inactivate-the-telomerase-chaperone-tcab1-in-osteosarcoma","Complex structural variations functionally inactivate the telomerase chaperone TCAB1 in osteosarcoma","","Alternative lengthening of telomeres (ALT) supports cellular immortalization in a large share of pediatric osteosarcoma cases, yet the full genetic spectrum driving ALT activation remains poorly defined. Osteosarcomas often carry inactivating alterations in the tumor suppressor TP53, including structural variants within TP53’s first intron that fully disrupt gene function. This work links TP53 structural variants to functional loss of TCAB1 (WRAP53), an essential RNA chaperone for telomerase holoenzyme trafficking and activity. Whole-genome sequencing reveals TCAB1 structural variants in ~40% of ALT-positive tumors, indicating early, previously unrecognized functional inactivation contributing to ALT activation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/complex-structural-variations-functionally-inactivate-the-telomerase-chaperone-tcab1-in-osteosarcoma/356053/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/complex-structural-variations-functionally-inactivate-the-telomerase-chaperone-tcab1-in-osteosarcoma/356053.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does ALT play in osteosarcoma?","Question",{"text":112,"@type":113},"ALT drives telomere elongation through homologous recombination and accounts for cellular immortalization in a large fraction of pediatric osteosarcoma cases.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are TCAB1 and telomerase activity connected?",{"text":117,"@type":113},"TCAB1 (WRAP53) acts as an RNA chaperone that enables trafficking of telomerase RNA (hTR) in the nucleus for proper telomerase assembly and localization to telomere ends.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about TCAB1 in ALT-positive osteosarcoma?",{"text":121,"@type":113},"Whole-genome sequencing identified structural variants within the TP53 gene that also inactivate TCAB1, occurring in about 40% of ALT-positive osteosarcoma tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356053,1790440092,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Keegan et al. BMC Cancer (2026) 26:948 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16250-5](https://doi.org/10.1186/s12885-026-16250-5)  \nRESEARCH Open Access  \nComplex structural variations functionally inactivate the telomerase chaperone TCAB1  \nin osteosarcoma  \nJoshua Keegan1†, Sydney Sorbello1,2†, Joakin Mori4, Shugo Muratani4, Ignaty Leshchiner4, Christopher M. Heaphy3,4 and Rachel L. Flynn 1,4*  \nAbstract  \nActivation of the alternative lengthening of telomeres (ALT) pathway accounts for cellular immortalization in 75% of pediatric osteosarcoma. ALT does not rely on a single enzyme but instead, catalyzes telomere elongation via homologous recombination. There has been steady progress in defining the mechanisms that regulate the ALT pathway. However, the spectrum of genetic mutations that underlie activation of ALT remains unclear. Osteosarcomas, like many cancers, frequently harbor inactivating mutations in the tumor suppressor gene TP53 . However, instead of single nucleotide variants that lead to expression of mutant TP53 protein, osteosarcoma tumors often acquire unique structural variants (SVs) within the first intron of the TP53 gene leading to complete gene inactivation. TP53 is located on chromosome 17p13 .1 in a head-to-head orientation and partially overlapping with the gene WRAP53 (WD repeat containing antisense to TP53) . WRAP53, also known as TCAB1, is an RNA chaperone that is an essential component of the telomerase holoenzyme. TCAB1 functions to facilitate trafficking of the telomerase RNA (hTR) within the nucleus to ensure assembly and localization of the telomerase enzyme to telomere ends to promote telomere elongation. Loss ofTCAB1 function abolishes telomerase activity, driving progressive telomere attrition. Here, using whole-genome sequencing of osteosarcoma samples we identified SVs within the TP53 gene that not only compromise TP53, but also inactivate TCAB1 . These TCAB1 SVs were prevalent in approximately 40% of ALT positive osteosarcoma tumors suggesting that functional inactivation of the telomerase holoenzyme is an early and previously unrecognized event contributing to the activation of the ALT pathway. Keywords Alternative lengthening of telomeres, Telomerase, Osteosarcoma, Genomic instability, Structural variants, TP53, WRAP53/TCAB1  \n†Joshua Keegan and Sydney Sorbello contributed equally to this work.  \n*Correspondence: Rachel L. Flynn [rlflynn@bu.edu](rlflynn@bu.edu)  \n1Department of Pharmacology, Physiology & Biophysics, Boston, MA 02118, USA  \n2Bioinformatics Program, Faculty of Computing and Data Science, Boston University, Boston, MA 02118, USA  \n3Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA  \n4Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nKeegan et al. ","cbCaitIrbPp3MlLZ","https://ap.wps.com/l/cbCaitIrbPp3MlLZ","pdf",2303974,14,"English","# Abstract\n# Introduction\n## Telomere shortening and cancer mechanisms\n## Telomerase reactivation vs ALT pathway","[{\"question\":\"What role does ALT play in osteosarcoma?\",\"answer\":\"ALT drives telomere elongation through homologous recombination and accounts for cellular immortalization in a large fraction of pediatric osteosarcoma cases.\"},{\"question\":\"How are TCAB1 and telomerase activity connected?\",\"answer\":\"TCAB1 (WRAP53) acts as an RNA chaperone that enables trafficking of telomerase RNA (hTR) in the nucleus for proper telomerase assembly and localization to telomere ends.\"},{\"question\":\"What did the study find about TCAB1 in ALT-positive osteosarcoma?\",\"answer\":\"Whole-genome sequencing identified structural variants within the TP53 gene that also inactivate TCAB1, occurring in about 40% of ALT-positive osteosarcoma tumors.\"}]","Complex structural variations functionally inactivate the telomerase chaperone TCAB1 in osteosarcoma | PDF",1790123020,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9c79cc6afc0872079a15b9f7a47cb2b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e58689e2849ebf42b35fb97cc4882bc.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fff0098408114b1b3462d11571bf1a2.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae96a8b048f65dbad73ae852d4b22c5a.webp",980,1306]